Top 5 Risers |
||||
Stock | Rating | Analysis | ||
AU | STRONGBUY | The projected value for AngloGold is still rising quickly even though past earnings have already improved significantly. | ||
DAL | STRONGBUY | Delta has shown significant advances in achieving substantial earnings growth recently, and analysts also appear confident these higher earnings will continue to grow in the near future. | ||
MAS | STRONGBUY | The projected value for Masco is still rising quickly even though past earnings have already improved significantly. | ||
SPPI | STRONGBUY | Spectrum Pharmaceuticals has been gaining recognition from analysts as a good canditate for achieving higher than expected earnings along with higher overall projected valuation. | ||
MLNX | STRONGBUY | Mellanox has shown a remarkable increase in projected value recently, with the majority of analysts expecting higher than previously expected earnings. |
Stocks